Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the Blood-Brain Barrier in Stress Resilience: Investigating New Pathways Towards Pharmacological Augmentation of Stress Resilience (a PHASR-PP Project Study)

NCT06965868 is registered in ClinicalTrials.gov with Leibniz-Institut für Resilienzforschung (LIR) gGmbH as lead sponsor.

NCT NCT06965868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the Blood-Brain Barrier in Stress Resilience: Investigating New Pathways Towards Pharmacological Augmentation of Stress Resilience (a PHASR-PP Project Study)
Lead sponsor
Leibniz-Institut für Resilienzforschung (LIR) gGmbH
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
February 28, 2027
Enrollment
122 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

blood-brain barrier integrity, mental health, stress resilience